Drugs / MP-3180
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 11 trial | ||||||
| Phase 1 | NCT02098174 | Nov 2013 → Jan 2014 | acute kidney injury | MediBeacon | Completed | No outcome recorded |
| Comparator or background therapy1 trial | ||||||
| Phase 1 | NCT02098187 Comparator | Mar 2014 | acute kidney injury | MediBeacon | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | MP-3180 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02098174 ↗ |
| Modality | Diagnostic / imaging agent | “(fluorescent tracer agent)” NCT02098174 ↗ |
| Route | Intravenous | “was administered by IV injection” NCT02098174 ↗ |